generic drug

Bucks Blog: Want the Lowest Drug Price? Make Sure to Ask

In its latest analysis of prescription drug prices, Consumer Reports comes up with some advice that sounds almost retro: when shopping for medicine, ask for the lowest possible price.

You might expect that you would automatically get the lowest price, but that’s not always the case, said Lisa Gill, prescription drugs editor at Consumer Reports. In fact, she said, you should ask for the lowest price even if you have health insurance that covers prescription drugs.

“In some cases, the cash retail price may be cheaper than your co-pay,” Ms. Gill said.

The national average generic drug co-payment is $10, but many chain stores offer hundreds of generics for $4. And the magazine’s analysis found that at Costco, the cost of a one-month supply of the generic equivalent of Lexapro, an antidepressant, was $7 for nonmembers. A small difference in price can mean a lot to someone on a fixed income, or to someone who lacks drug coverage. Seniors and students may also qualify for discounts — but again, you have to ask.

For the analysis, “secret shoppers” called 200 pharmacies nationwide and asked for the retail price (that is, the price paid by someone without health insurance) for a month’s supply of five big-name drugs that had just become available in generic versions: Actos (pioglitazone) for diabetes; Lexapro (escitalopram); Lipitor (atorvastatin) for high cholesterol; Plavix (clopidogrel), a blood thinner; and Singulair (montelukast) for asthma. The results showed a wide range of prices, and the difference between the highest and lowest price for the drugs as a group was more than 400 percent. “I was shocked,” Ms. Gill said.

The analysis found that Costco was the lowest-priced option for the group of drugs over all, and you don’t have to be a member to use its pharmacy. Even some independent pharmacies had lower prices, although they varied widely. But it’s worth asking if they’ll match a competitor’s price.

The prices at chain drugstores like CVS were higher, but they offer more services, like 24-hour pharmacies. So calling around for prices makes the most sense for longer-term maintenance drugs that you don’t need on an emergency basis. If you’re ill and in a hurry, choosing a location based on convenience makes sense.

How do you buy your prescription drugs? Do you check prices at different pharmacies, or choose by convenience?

Article source: http://bucks.blogs.nytimes.com/2013/04/03/want-the-lowest-drug-price-make-sure-to-ask/?partner=rss&emc=rss

Pfizer Is Said to Pursue Nonprescription Lipitor

Selling a version of the drug to consumers without a prescription would allow Pfizer to retain some of the $11 billion in annual revenue that Lipitor has been generating.

However, a nonprescription version would not be available immediately after the patent on Lipitor expires because Pfizer would first have to convince the Food and Drug Administration that consumers could take the drug without a doctor’s supervision.

That will probably be difficult. Merck failed three times to win the agency’s approval for over-the-counter versions of Mevacor, which, like Lipitor, is a statin. Bristol-Myers Squibb also failed to obtain approval for an over-the-counter version of Pravachol, another statin.

Pfizer declined to either confirm or deny its intention. “We can confirm that we have strategic plans in place for Lipitor’s loss of exclusivity and will comment no further at this time,” Raymond F. Kerins Jr., a spokesman for the company, said.

The person close to the situation, who would speak only anonymously because the discussions were private, said a nonprescription version of the drug was not the only option pursued by Pfizer. Another would be a so-called branded generic version. The company might pursue both options.

Pfizer announced last month that it was looking to sell or spin off animal health and baby formula businesses to streamline the company and help prepare for the loss of Lipitor sales to generic competitors.

But the company decided to keep two businesses that Wall Street had speculated might be sold: the generic drug business and the consumer business, which now sells products like Advil and Robitussin. That has led to speculation that the company was planning to sell generic and over-the-counter versions of Lipitor and other drugs that face a loss of patent protection.

Pfizer’s plans for the nonprescription Lipitor were first reported by The Wall Street Journal.

An over-the-counter version of Lipitor would no doubt be welcomed by insurers because it would cost less.

In the past, the F.D.A. advisers have been concerned that over-the counter versions of statins could not be used safely, that some patients who did not need the drugs would take them.

Others at significant risk of cardiovascular problems might take the over-the-counter drug and forgo seeing a doctor or getting other necessary care.

Since high cholesterol is a symptomless condition, consumers would not know whether the drug was working without having their cholesterol checked periodically.

But Steven Francesco of Francesco International, a consulting firm that specializes in converting brand name drugs to over-the-counter products, said technology such as prescription cards used at the drug store would better allow patients to be monitored without physician supervision.

“There’s any number of ways to insure that the consumer can use the drug,” said Mr. Francesco. “Lipitor will be one of the first of many drugs that will attempt to switch between now and 2016.”

Article source: http://feeds.nytimes.com/click.phdo?i=23694b17bf33d9c97b9d473529df4ec8

Bucks Blog: Want the Lowest Drug Price? Make Sure to Ask

Pfizer Is Said to Pursue Nonprescription Lipitor

Recent News

Partners